Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis. [electronic resource]
Producer: 20040621Description: 159-66 p. digitalISSN:- 0940-2993
- Actins -- analysis
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Animals
- Benzimidazoles -- therapeutic use
- Biphenyl Compounds
- Captopril -- therapeutic use
- Carbon Tetrachloride -- toxicity
- Cell Count
- Disease Models, Animal
- Immunohistochemistry
- Liver -- chemistry
- Liver Cirrhosis, Experimental -- drug therapy
- Male
- Rats
- Rats, Sprague-Dawley
- Tetrazoles -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.